Canton Strategic Holdings, Inc. (CNTN)Healthcare | Biotechnology | Red Bank, United States | NasdaqCM
2.22 USD
-0.13
(-5.532%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 2.23 +0.01 (0.369%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:34 a.m. EDT
The immediate outlook is severely clouded by a statistically weak forecast predicting a further decline over the next month, compounded by a price that has failed to recover from its massive collapse. While the recent trading session shows a temporary bounce off the lows, the broader trend remains deeply bearish, with the stock trading far below its moving averages and exhibiting high short interest that suggests continued selling pressure. Looking further ahead, the investment case is nearly non-existent; the company has suffered a catastrophic loss of value over the last three years, dropping nearly 99% from its peak. Although the most recent annual report showed a rebound in price, the underlying business fundamentals are dire, characterized by negative earnings, negative free cash flow, and a massive operating burn rate that continues to erode shareholder value. With no dividend to provide income and a balance sheet that appears to be funding a failing biotech strategy rather than generating sustainable returns, this security represents a high-risk speculative bet with no margin of safety. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.151088 |
| AutoETS | 0.157387 |
| MSTL | 0.157624 |
| AutoARIMA | 0.244118 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 0.37 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.274 |
| Excess Kurtosis | -1.09 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.019 |
| Market Cap | 176,892,624 |
| Beta | 1.47 |
| Previous Name | Hillstream BioPharma, Inc. |
| Website | https://www.cantonstrategic.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5480769 |
| Address1 | 34 Shrewsbury Avenue |
| Address2 | Suite 1C |
| All Time High | 1,590.0 |
| All Time Low | 0.952 |
| Ask | 2.85 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 741,940 |
| Average Daily Volume3 Month | 980,522 |
| Average Volume | 980,522 |
| Average Volume10Days | 741,940 |
| Beta | 1.47 |
| Bid | 1.7 |
| Bid Size | 2 |
| Book Value | 5.887 |
| City | Red Bank |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.22 |
| Current Ratio | 15.696 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.36 |
| Day Low | 2.2 |
| Display Name | Canton Strategic |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 93.358 |
| Enterprise Value | 139,651,056 |
| Eps Trailing Twelve Months | -0.14 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.3118 |
| Fifty Day Average Change | -0.091799974 |
| Fifty Day Average Change Percent | -0.039709307 |
| Fifty Two Week Change Percent | -54.807693 |
| Fifty Two Week High | 6.89 |
| Fifty Two Week High Change | -4.67 |
| Fifty Two Week High Change Percent | -0.6777939 |
| Fifty Two Week Low | 1.75 |
| Fifty Two Week Low Change | 0.47000003 |
| Fifty Two Week Low Change Percent | 0.26857144 |
| Fifty Two Week Range | 1.75 - 6.89 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,641,997,800,000 |
| Float Shares | 72,714,820 |
| Free Cashflow | -1,273,672 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 12 |
| Fullday Change | -0.13 |
| Fullday Change Percent | -5.53191 |
| Fullday Price | 2.2282 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 1,495,859 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16946 |
| Held Percent Institutions | 0.24923 |
| Implied Shares Outstanding | 79,681,361 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,716,854,400 |
| Last Split Factor | 1:15 |
| Long Business Summary | Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey. |
| Long Name | Canton Strategic Holdings, Inc. |
| Market | us_market |
| Market Cap | 176,892,624 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_529635023 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -96,094,728 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 187,649,605 |
| Open | 2.34 |
| Operating Cashflow | -22,170,276 |
| Operating Margins | -0.80364996 |
| Payout Ratio | 0.0 |
| Phone | 732 889 3111 |
| Post Market Change | 0.00819993 |
| Post Market Change Percent | 0.36936623 |
| Post Market Price | 2.2282 |
| Post Market Time | 1,787,959,806 |
| Prev Name | Hillstream BioPharma, Inc. |
| Previous Close | 2.35 |
| Price Hint | 4 |
| Price To Book | 0.37710208 |
| Price To Sales Trailing12 Months | 118.254875 |
| Profit Margins | 0.0 |
| Quick Ratio | 14.182 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.13 |
| Regular Market Change Percent | -5.53191 |
| Regular Market Day High | 2.36 |
| Regular Market Day Low | 2.2 |
| Regular Market Day Range | 2.2 - 2.36 |
| Regular Market Open | 2.34 |
| Regular Market Previous Close | 2.35 |
| Regular Market Price | 2.22 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 516,240 |
| Return On Assets | -0.11695 |
| Return On Equity | -0.42214 |
| Revenue Per Share | 0.019 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 79,681,361 |
| Shares Percent Shares Out | 0.09810001 |
| Shares Short | 7,816,403 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 7,778,704 |
| Short Name | Canton Strategic Holdings, Inc. |
| Short Percent Of Float | 0.0994 |
| Short Ratio | 10.99 |
| Source Interval | 15 |
| State | NJ |
| Symbol | CNTN |
| Total Cash | 37,241,568 |
| Total Cash Per Share | 0.467 |
| Total Debt | 0 |
| Total Revenue | 1,495,859 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.14 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.09845 |
| Two Hundred Day Average Change | -0.8784499 |
| Two Hundred Day Average Change Percent | -0.2835127 |
| Type Disp | Equity |
| Volume | 516,240 |
| Website | https://www.cantonstrategic.com |
| Zip | 7,701 |